{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:44:46Z","timestamp":1766159086580},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,7]]},"DOI":"10.7759\/cureus.33486","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T16:42:56Z","timestamp":1673109776000},"source":"Crossref","is-referenced-by-count":5,"title":["Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies"],"prefix":"10.7759","author":[{"given":"Hammaad A","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2008.05.624","article-title":"Research priorities in spasmodic dysphonia","volume":"139","author":"Ludlow CL","year":"2008","unstructured":"Ludlow CL, Adler CH, Berke GS, et al.. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008, 139:495-505. 10.1016\/j.otohns.2008.05.624","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20572","article-title":"Differentiating between adductor and abductor spasmodic dysphonia using airflow interruption","volume":"119","author":"Hoffman MR","year":"2009","unstructured":"Hoffman MR, Jiang JJ, Rieves AL, McElveen KA, Ford CN. Differentiating between adductor and abductor spasmodic dysphonia using airflow interruption. Laryngoscope. 2009, 119:1851-5. 10.1002\/lary.20572","journal-title":"Laryngoscope"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27617","article-title":"A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia","volume":"129","author":"Guiry S","year":"2019","unstructured":"Guiry S, Worthley A, Simonyan K. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia. Laryngoscope. 2019, 129:1627-33. 10.1002\/lary.27617","journal-title":"Laryngoscope"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2021.07.026","article-title":"Neurectomy and myomectomy for treatment of spasmodic dysphonia [in press]","author":"Ryan W","year":"2022","unstructured":"Ryan W, Alnouri G, Sataloff RT. Neurectomy and myomectomy for treatment of spasmodic dysphonia [in press]. J Voice. 2022, 10.1016\/j.jvoice.2021.07.026","journal-title":"J Voice"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2022.05.012","article-title":"Spasmodic dysphonia: an overview of clinical features and treatment options [in press]","author":"Sanuki T","year":"2022","unstructured":"Sanuki T. Spasmodic dysphonia: an overview of clinical features and treatment options [in press]. Auris Nasus Larynx. 2022, 10.1016\/j.anl.2022.05.012","journal-title":"Auris Nasus Larynx"},{"key":"ref6","article-title":"Laryngeal Botulinum Toxin Injection","author":"Biello A","year":"2022","unstructured":"Biello A, Volner K, Song SA. Laryngeal Botulinum Toxin Injection. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2013.10.024","article-title":"Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues","volume":"28","author":"Young DL","year":"2014","unstructured":"Young DL, Halstead LA. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues. J Voice. 2014, 28:614-7. 10.1016\/j.jvoice.2013.10.024","journal-title":"J Voice"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2009.08.003","article-title":"Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor","volume":"25","author":"Kendall KA","year":"2011","unstructured":"Kendall KA, Leonard RJ. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor. J Voice. 2011, 25:114-9. 10.1016\/j.jvoice.2009.08.003","journal-title":"J Voice"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/000348941212100408","article-title":"Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study","volume":"121","author":"Mendelsohn AH","year":"2012","unstructured":"Mendelsohn AH, Berke GS. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study. Ann Otol Rhinol Laryngol. 2012, 121:231-8. 10.1177\/000348941212100408","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0194599813484685","article-title":"Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia","volume":"148","author":"Rosow DE","year":"2013","unstructured":"Rosow DE, Parikh P, Vivero RJ, Casiano RR, Lundy DS. Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia. Otolaryngol Head Neck Surg. 2013, 148:1003-6. 10.1177\/0194599813484685","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2239-5","article-title":"Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin","volume":"36","author":"Esposito M","year":"2015","unstructured":"Esposito M, Dubbioso R, Apisa P, Allocca R, Santoro L, Cesari U. Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin. Neurol Sci. 2015, 36:1679-82. 10.1007\/s10072-015-2239-5","journal-title":"Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2014.08.011","article-title":"Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients","volume":"29","author":"Rosow DE","year":"2015","unstructured":"Rosow DE, Pechman A, Saint-Victor S, Lo K, Lundy DS, Casiano RR. Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients. J Voice. 2015, 29:352-5. 10.1016\/j.jvoice.2014.08.011","journal-title":"J Voice"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2016.09.022","article-title":"Botulinum toxin-A dosing trends for adductor spasmodic dysphonia at a single institution over 10 years","volume":"31","author":"Bradley JP","year":"2017","unstructured":"Bradley JP, Barrow EM, Hapner ER, Klein AM, Johns MM 3rd. Botulinum toxin-A dosing trends for adductor spasmodic dysphonia at a single institution over 10 years. J Voice. 2017, 31:363-5. 10.1016\/j.jvoice.2016.09.022","journal-title":"J Voice"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28105","article-title":"Adductor spasmodic dysphonia: botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective","volume":"130","author":"Schuering JH","year":"2020","unstructured":"Schuering JH, Heijnen BJ, Sj\u00f6gren EV, Langeveld AP. Adductor spasmodic dysphonia: botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective. Laryngoscope. 2020, 130:741-6. 10.1002\/lary.28105","journal-title":"Laryngoscope"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26265","article-title":"Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia","volume":"127","author":"Lerner MZ","year":"2017","unstructured":"Lerner MZ, Lerner BA, Patel AA, Blitzer A. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia. Laryngoscope. 2017, 127:1131-4. 10.1002\/lary.26265","journal-title":"Laryngoscope"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.1745","article-title":"Association of laryngeal botulinum neurotoxin injection with work productivity for patients with spasmodic dysphonia","volume":"147","author":"Meyer TK","year":"2021","unstructured":"Meyer TK, Spiekerman C, Kaye R, Blitzer A, Kamizi RS, Jiang L, Weaver EM. Association of laryngeal botulinum neurotoxin injection with work productivity for patients with spasmodic dysphonia. JAMA Otolaryngol Head Neck Surg. 2021, 147:804-10. 10.1001\/jamaoto.2021.1745","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13120840","article-title":"Botulinum toxin therapy: a series of clinical studies on patients with spasmodic dysphonia in Japan","volume":"13","author":"Hyodo M","year":"2021","unstructured":"Hyodo M, Asano K, Nagao A, Hirose K, Nakahira M, Yanagida S, Nishizawa N. Botulinum toxin therapy: a series of clinical studies on patients with spasmodic dysphonia in Japan. Toxins (Basel). 2021, 13:840. 10.3390\/toxins13120840","journal-title":"Toxins (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.669","article-title":"Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan","volume":"6","author":"Hirose K","year":"2021","unstructured":"Hirose K, Asano K, Sakaguchi M, et al.. Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan. Laryngoscope Investig Otolaryngol. 2021, 6:1088-95. 10.1002\/lio2.669","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2022.07.021","article-title":"Simultaneous botox and augmentation injection laryngoplasty in patients with adductor spasmodic dysphonia (ASD) and tremor","author":"Woo P","year":"2022","unstructured":"Woo P. Simultaneous botox and augmentation injection laryngoplasty in patients with adductor spasmodic dysphonia (ASD) and tremor. J Voice. 2022, 10.1016\/j.jvoice.2022.07.021","journal-title":"J Voice"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2020.04.037","article-title":"Patient experience contributing to outcomes of laryngeal botulinum toxin injection","volume":"36","author":"Rutt A","year":"2022","unstructured":"Rutt A, Kennelly KD, Martinez-Paredes JF. Patient experience contributing to outcomes of laryngeal botulinum toxin injection. J Voice. 2022, 36:272-6. 10.1016\/j.jvoice.2020.04.037","journal-title":"J Voice"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.915","article-title":"Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: a 31-year experience","volume":"7","author":"Stone A","year":"2022","unstructured":"Stone A, Powell ME, Hamers K, et al.. Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: a 31-year experience. Laryngoscope Investig Otolaryngol. 2022, 7:1499-505. 10.1002\/lio2.915","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103613","article-title":"IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: a prospective, open-label clinical trial","volume":"43","author":"Kohli N","year":"2022","unstructured":"Kohli N, Lerner M, Rashty J, Kirke D, Stewart T, Blitzer A. IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: a prospective, open-label clinical trial. Am J Otolaryngol. 2022, 43:103613. 10.1016\/j.amjoto.2022.103613","journal-title":"Am J Otolaryngol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107948-use-of-botulinum-toxin-in-spasmodic-dysphonia-a-review-of-recent-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:01Z","timestamp":1707508381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107948-use-of-botulinum-toxin-in-spasmodic-dysphonia-a-review-of-recent-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.33486","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,7]]}}}